Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest update is out from Lee’s Pharmaceutical Holdings Limited ( (HK:0950) ).
Lee’s Pharmaceutical Holdings Limited held its Annual General Meeting on May 22, 2025, where all proposed resolutions were passed. Key resolutions included the approval of audited financial statements, declaration of a final dividend, re-election of directors, and granting of mandates for share repurchase and issuance. The successful passing of these resolutions indicates strong shareholder support and positions the company for continued operational stability and strategic growth.
More about Lee’s Pharmaceutical Holdings Limited
Lee’s Pharmaceutical Holdings Limited is a company incorporated in the Cayman Islands, primarily engaged in the pharmaceutical industry. It focuses on the development, manufacturing, and distribution of pharmaceutical products, with a market presence in Hong Kong.
Average Trading Volume: 304,484
Technical Sentiment Signal: Buy
Current Market Cap: HK$830.3M
Find detailed analytics on 0950 stock on TipRanks’ Stock Analysis page.